Search research articles
Contact Us
Filters
Showing results (81-90 of 89) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 89 results.
Histochemistry and Cell Biology
|
April 13, 2005
Design, synthesis, physical and chemical characterisation, and biological interactions of lectin-targeted latex nanoparticles bearing Gd-DTPA chelates: an exploration of magnetic resonance molecular imaging (MRMI)
Irena Paschkunova-Martic, Christian Kremser, Klaudia Mistlberger, et al.
Biological Procedures Online
|
July 27, 2025
Comprehensive Insights into APOBEC Mutations in Thyroid Cancer: Prognostic and Therapeutic Discoveries
Wei Luo, Feng Liu, Mengyu Li, et al.
Journal of the National Cancer Center
|
June 12, 2026
Efficacy and safety comparisons of PD-1 versus PD-L1 inhibitors in patients with solid cancer: a systematic review and meta-analysis
Jun Yu, Qiaoxia Zhou, Guoqiang Wang, et al.
Plant Communications
|
June 18, 2026
PUB13-Mediated Degradation of PBS3 Regulates Salicylic Acid Biosynthesis to Coordinate Plant Immunity and Leaf Longevity
Jinyu He, Wei Li, Yunsheng Yang, et al.
Signal Transduction and Targeted Therapy
|
April 27, 2026
Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer
Xiaofan Guo, Yuxiao Liu, Tianchen Li, et al.
Cancer Letters
|
December 22, 2024
The nuclear condensates of ESE3/EHF induce cellular senescence without the associated inflammatory secretory phenotype in pancreatic ductal adenocarcinoma
Tianxing Zhou, Jingrui Yan, Bohang Xu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
January 20, 2026
Pathomics Signature for Prognosis and CA19-9 Interception in Pancreatic Ductal Adenocarcinoma: A Real-Life, Multi-Center Study
Qiangda Chen, Zhihang Xu, Yiping Zou, et al.
Gut
|
August 26, 2024
CD64<sup>+</sup> fibroblast-targeted vilanterol and a STING agonist augment CLDN18.2 BiTEs efficacy against pancreatic cancer by reducing desmoplasia and enriching stem-like CD8<sup>+</sup> T cells
Tianxing Zhou, Xupeng Hou, Jingrui Yan, et al.
Nature Communications
|
December 5, 2025
Targeting TNK2/ACK1 reverses the immunosuppressive tumor microenvironment and synergizes with immunochemotherapy in pancreatic cancer
Chao Wu, Weishuai Liu, Xiangting Hu, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 89) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 89 results.
Histochemistry and Cell Biology
|
April 13, 2005
Design, synthesis, physical and chemical characterisation, and biological interactions of lectin-targeted latex nanoparticles bearing Gd-DTPA chelates: an exploration of magnetic resonance molecular imaging (MRMI)
Irena Paschkunova-Martic, Christian Kremser, Klaudia Mistlberger, et al.
Biological Procedures Online
|
July 27, 2025
Comprehensive Insights into APOBEC Mutations in Thyroid Cancer: Prognostic and Therapeutic Discoveries
Wei Luo, Feng Liu, Mengyu Li, et al.
Journal of the National Cancer Center
|
June 12, 2026
Efficacy and safety comparisons of PD-1 versus PD-L1 inhibitors in patients with solid cancer: a systematic review and meta-analysis
Jun Yu, Qiaoxia Zhou, Guoqiang Wang, et al.
Plant Communications
|
June 18, 2026
PUB13-Mediated Degradation of PBS3 Regulates Salicylic Acid Biosynthesis to Coordinate Plant Immunity and Leaf Longevity
Jinyu He, Wei Li, Yunsheng Yang, et al.
Signal Transduction and Targeted Therapy
|
April 27, 2026
Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer
Xiaofan Guo, Yuxiao Liu, Tianchen Li, et al.
Cancer Letters
|
December 22, 2024
The nuclear condensates of ESE3/EHF induce cellular senescence without the associated inflammatory secretory phenotype in pancreatic ductal adenocarcinoma
Tianxing Zhou, Jingrui Yan, Bohang Xu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
January 20, 2026
Pathomics Signature for Prognosis and CA19-9 Interception in Pancreatic Ductal Adenocarcinoma: A Real-Life, Multi-Center Study
Qiangda Chen, Zhihang Xu, Yiping Zou, et al.
Gut
|
August 26, 2024
CD64<sup>+</sup> fibroblast-targeted vilanterol and a STING agonist augment CLDN18.2 BiTEs efficacy against pancreatic cancer by reducing desmoplasia and enriching stem-like CD8<sup>+</sup> T cells
Tianxing Zhou, Xupeng Hou, Jingrui Yan, et al.
Nature Communications
|
December 5, 2025
Targeting TNK2/ACK1 reverses the immunosuppressive tumor microenvironment and synergizes with immunochemotherapy in pancreatic cancer
Chao Wu, Weishuai Liu, Xiangting Hu, et al.
Page
of 9